Deferred Tax Assets, Valuation Allowance in GBP of TC BioPharm (Holdings) plc from Q4 2022 to Q4 2024

Taxonomy & unit
us-gaap: GBP
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
TC BioPharm (Holdings) plc quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2022 to Q4 2024.
  • TC BioPharm (Holdings) plc Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was £6.27M, a 40.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (GBP)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

TC BioPharm (Holdings) plc Quarterly Deferred Tax Assets, Valuation Allowance (GBP)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 6.27M +1.82M +40.8% 31 Dec 2024 20-F 09 May 2025
Q4 2023 4.45M -358K -7.44% 31 Dec 2023 20-F 09 May 2025
Q4 2022 4.81M 31 Dec 2022 10-K 01 Apr 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.